FDC
Ronak Barot is an experienced professional in portfolio strategy and business development, currently serving as DGM - Portfolio Strategy at FDC Limited since October 2021. With previous roles at Zydus Group as Lead Business Development and Portfolio and at Cipla in Corporate Strategy, Ronak has demonstrated expertise in business associate engagement, brand asset identification, and market analysis. Additional roles at Panacea Biotec Ltd, DMV Business and Market Research Pvt. Ltd., SmartAnalyst, and Torrent Pharmaceuticals Ltd have further solidified skills in market research, strategy development, and competitive intelligence. Ronak holds an MBA in Pharmaceutical Marketing and Management from SIES College of Management Studies and a B Pharm in Pharmaceutical Sciences from Bharati Vidyapeeth.
This person is not in any teams
FDC
FDC Limited is a pharmaceutical company. The Company is engaged in manufacture of specialized formulations, and oral rehydration salts (ORS). Its therapeutic areas of focus include anti-infectives, gastrointestinals, ophthalmologicals, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology and analgesics. It has a range of functional foods and beverages. Its active pharmaceuticals ingredients (APIs) produced cover a range of therapeutic categories, such as Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate. Its brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm. It has multi-location manufacturing facilities for APIs, as well as finished dosage forms. Its facilities are located at Roha, Waluj and Sinnar in Maharashtra, Verna in Goa and Baddi in Himachal Pradesh.